Literature DB >> 19318438

Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors.

Carrie M Nielson1, Robin B Harris, Roberto Flores, Martha Abrahamsen, Mary R Papenfuss, Eileen F Dunne, Lauri E Markowitz, Anna R Giuliano.   

Abstract

Human papillomavirus (HPV) causes cervical cancer and is strongly associated with other anogenital cancers. Multiple-type HPV infection has been associated with lengthier infection and precancerous lesions. Little is known about multiple-type HPV prevalence and associated factors in men. We examined the prevalence of and risk factors for multiple-type HPV in primarily asymptomatic men. Detection of 37 HPV types in male anogenital epithelium and semen was completed in 463 men in two U.S. cities. The proportions of men with multiple HPV of any type and with multiple oncogenic or nononcogenic types were calculated. Factors associated with multiple HPV were evaluated using multinomial logistic regression. Overall, 22.9% of men had multiple-HPV, 8.6% of men had multiple oncogenic types, and 13.4% had multiple nononcogenic types. Greater proportions of samples at the shaft, glans/corona, and scrotum had multiple HPV types (18.7%, 12.8%, and 7.3%, respectively) than did other anogenital sites (all < or =2.8%). Factors independently associated with multiple-type HPV were Hispanic ethnicity [adjusted odds ratio (AOR), 2.45; 95% confidence interval (95% CI), 1.05-5.67], concurrent detection of genital warts (AOR, 10.40; 95% CI, 1.12-96.6), smoking > or =10 cigarettes/d (AOR, 3.00; 95% CI, 1.07-8.43), greater lifetime number of female sexual partners (AOR, 13.73 for > or =21 versus 1-5; 95% CI, 5.34-35.3), and condom use less than half the time (AOR, 2.03; 95% CI, 1.07-3.84). Detection of multiple HPV types in this study of primarily asymptomatic men was common, particularly at external genital sites. Lifetime number of female sex partners, condom use, and smoking were modifiable factors associated with multiple HPV.

Entities:  

Mesh:

Year:  2009        PMID: 19318438      PMCID: PMC5415340          DOI: 10.1158/1055-9965.EPI-08-0447

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads.

Authors:  Maaike C G Bleeker; Cornelis J A Hogewoning; Johannes Berkhof; Feja J Voorhorst; Albertus T Hesselink; Pien M van Diemen; Adriaan J C van den Brule; Peter J F Snijders; Chris J L M Meijer
Journal:  Clin Infect Dis       Date:  2005-07-25       Impact factor: 9.079

3.  Human papillomavirus infections with multiple types and risk of cervical neoplasia.

Authors:  Helen Trottier; Salaheddin Mahmud; Maria Cecilia Costa; João P Sobrinho; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

4.  Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.

Authors:  M C Rousseau; J S Pereira; J C Prado; L L Villa; T E Rohan; E L Franco
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.

Authors:  R Herrero; A Hildesheim; C Bratti; M E Sherman; M Hutchinson; J Morales; I Balmaceda; M D Greenberg; M Alfaro; R D Burk; S Wacholder; M Plummer; M Schiffman
Journal:  J Natl Cancer Inst       Date:  2000-03-15       Impact factor: 13.506

7.  Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico.

Authors:  Salvatore Vaccarella; Eduardo Lazcano-Ponce; José Antonio Castro-Garduño; Aurelio Cruz-Valdez; Vicente Díaz; Rafaela Schiavon; Pilar Hernández; Janet R Kornegay; Mauricio Hernández-Avila; Silvia Franceschi
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

8.  Risk factors for anogenital human papillomavirus infection in men.

Authors:  Carrie M Nielson; Robin B Harris; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Roberto Flores; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

9.  Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Authors:  Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

10.  Human papillomavirus prevalence and type distribution in male anogenital sites and semen.

Authors:  Carrie M Nielson; Roberto Flores; Robin B Harris; Martha Abrahamsen; Mary R Papenfuss; Eileen F Dunne; Lauri E Markowitz; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

View more
  36 in total

1.  [Proven and new methods in the treatment of genital warts].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

2.  The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection.

Authors:  Luis F Barroso
Journal:  Ther Adv Vaccines       Date:  2013-07

3.  Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .

Authors:  Dr M Dawar; Ms T Harris; Dr S McNeil
Journal:  Can Commun Dis Rep       Date:  2012-01-02

4.  Bovine papillomavirus E2 and E5 gene expression in sperm cells of healthy bulls.

Authors:  M A R Silva; E C B Silva; A P A D Gurgel; K C G Nascimento; A C Freitas
Journal:  Virusdisease       Date:  2013-11-30

5.  Quality of life of homosexual males with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Res Notes       Date:  2010-11-04

6.  Multiple human papillomavirus infections and type competition in men.

Authors:  Anne F Rositch; Charles Poole; Michael G Hudgens; Kawango Agot; Edith Nyagaya; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2011-11-04       Impact factor: 5.226

7.  Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Authors:  Rayleen M Lewis; Lauri E Markowitz; Julia W Gargano; Martin Steinau; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

Review 8.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

9.  HPV knowledge and vaccine acceptability among Hispanic fathers.

Authors:  Julie Kornfeld; Margaret M Byrne; Robin Vanderpool; Sarah Shin; Erin Kobetz
Journal:  J Prim Prev       Date:  2013-04

10.  HPV vaccination among adolescent males: results from the National Immunization Survey-Teen.

Authors:  Paul L Reiter; Melissa B Gilkey; Noel T Brewer
Journal:  Vaccine       Date:  2013-04-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.